Rdos. 3T'22 vs 3T'21:
Rentas brutas: 92,0 M euros (+16,5% vs +11,4% BS(e));
EBITDA: 76,0 M euros (+15,2% vs +7,6% BS(e));
BPA recurrente: 0,08 euros (+8% vs +7% BS(e)).
Rdos. 9meses'22 vs 9meses'21:
Rentas brutas: 262,0 M euros (+12,0% vs +10,3% BS(e));
EBITDA: 205,0 M euros (+11,4% vs +8,7% BS(e)).
BPA recurrente: 0,22 euros (23% vs +22% BS(e)).